Carriers of DRB1*15:01 have higher EBNA-1 antibody levels compared to DRB1*15:01 negative individuals, both among MS patients and healthy controls (36, 68), indicating a defective immune response to EBV. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.